News Briefs

HHS on Sept. 9 issued guidance that authorizes state-licensed pharmacists to order and administer COVID-19 vaccines to people ages 3 and up — when they’re authorized or licensed by the FDA and made available to the public. “Allowing pharmacists to order and administer COVID-19 vaccines will greatly expand convenient access for the American people,” said Assistant Secretary for Health ADM Brett P. Giroir, M.D. To qualify for vaccine administration, pharmacists or registered pharmacy interns must meet a variety of requirements, such as completing a training program. Read more about the guidance at https://bit.ly/3if2tDR.

The CEOs of nine pharmaceutical companies on Sept. 8 issued a “historic pledge” aimed at bolstering public confidence that they will develop and test potential COVID-19 vaccines “in accordance with high ethical standards and sound scientific principles.” The pledge — signed by the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline plc, Johnson & Johnson, Merck, Moderna, Inc., Novavax, Inc. Pfizer Inc. and Sanofi — comes amid mounting worries that the Trump administration will put political pressure on drug companies to seek premature approval of a vaccine for the coronavirus. Among other promises, the companies said they will only submit a vaccine for FDA approval or emergency use authorization after it demonstrates safety and efficacy through a well-designed Phase 3 clinical study. Read the pledge at https://bwnews.pr/2FfEvtn.

© 2023 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

bills-and-pills
January 26

Medicare Enrollees May Still Face Affordability Issues After Part D Benefit Redesign

READ MORE
pills-in-hand
January 26

ICER Report Aims to Nudge Payers Toward Fairer Drug Coverage Policies

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
January 26

News Briefs: Lilly Alzheimer’s Drug Fails to Win Accelerated Approval

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today